Home Cart Sign in  
Chemical Structure| 104091-08-9 Chemical Structure| 104091-08-9
Chemical Structure| 104091-08-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fmoc-D-Glu(OtBu)-OH is a protected D-glutamic acid derivative with the amino group protected by 9-fluorenylmethoxycarbonyl (Fmoc) and the carboxyl group esterified by tert-butyl, suitable for peptide synthesis.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Ogawa, Kazuma ; Nishizawa, Kota ; Mishiro, Kenji ; Munekane, Masayuki ; Fuchigami, Takeshi ; Echigo, Hiroaki , et al.

Abstract: Acidic amino acid peptides have a high affinity for bone. Previously, we demonstrated that radiogallium complex-conjugated oligo-acidic amino acids possess promising properties as bone-seeking radiopharmaceuticals. Here, to elucidate the effect of stereoisomers of Glu in Glu-containing peptides [(Glu)14] on their accumulation in the kidney, the biodistributions of [67Ga]Ga-N,N′ -bis-[2-hydroxy- 5-(carboxyethyl)benzyl]ethylenediamine-N,N′ -diacetic acid-conjugated (L-Glu)14 ([67Ga]Ga-HBED-CC- (L-Glu)14), [67Ga]Ga-HBED-CC-(D-Glu)14, [67Ga]Ga-HBED-CC-(DL-Glu)14, and [67Ga]Ga-HBED-CC- (D-Glu-L-Glu)7 were compared. Although the accumulation of these compounds in the bone was comparable, their kidney accumulation and retention were strikingly different, with [67Ga]Ga-HBED-CC- (D-Glu-L-Glu)7 exhibiting the lowest level of kidney accumulation among these compounds. Repeated D- and L-peptides may be a useful method for reducing renal accumulation in some cases.

Keywords: kidney accumulation ; bone imaging ; ; bone metastases ; gallium

Purchased from AmBeed: ;

Alternative Products

Product Details of Fmoc-D-Glu(OtBu)-OH

CAS No. :104091-08-9
Formula : C24H27NO6
M.W : 425.47
SMILES Code : O=C(O)[C@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)CCC(OC(C)(C)C)=O
MDL No. :MFCD00077055
InChI Key :OTKXCALUHMPIGM-HXUWFJFHSA-N
Pubchem ID :7018822

Safety of Fmoc-D-Glu(OtBu)-OH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of Fmoc-D-Glu(OtBu)-OH

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 104091-08-9 ]

[ 104091-08-9 ] Synthesis Path-Downstream   1~36

  • 1
  • C14H24N3O7Pol [ No CAS ]
  • [ 104091-08-9 ]
  • C38H49N4O12Pol [ No CAS ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; for 1h; Commercially available Nalpha-(9-Fluorenylmethoxycarbonyl)-D-glutamic acid 7-t-butyl ester (1.14 g), TBTU (0.87 g), HOBt (0.37 g) and DIPEA (940 muL) as a solution in NMP (20 mL) was added to compound 5. The reaction mixture was shaken for one hour. The reaction mixture was filtered through a glass sinter funnel then the solid was washed with N-methylpyrrolidine (3×15 mL), methanol (3×15 mL), and again with N-methylpyrrolidine (3×15 mL). The reaction was judged to be complete using the Kaiser Test (vide supra), yielding the resin bound compound 79.
  • 2
  • C18H31N4O8Pol [ No CAS ]
  • [ 104091-08-9 ]
  • C42H56N5O13Pol [ No CAS ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; for 17h; Commercially available Nalpha-(9-Fluorenylmethoxycarbonyl)-D-glutamic acid gamma-t-butyl ester (0.98 g), TBTU (0.74 g), HOBt (0.31 g) and DIPEA (810 muL) as a solution in NMP (20 mL) was added to compound 71 (1.8 g). The reaction mixture was shaken for seventeen hours. The reaction mixture was filtered through a glass sinter funnel then the solid was washed with N-methylpyrrolidine (3×15 mL), methanol (3×15 mL), and again with N-methylpyrrolidine (3×15 mL) to give compound 85.
  • 3
  • C25H44N5O10Pol [ No CAS ]
  • [ 104091-08-9 ]
  • C49H69N6O15Pol [ No CAS ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine; In 1-methyl-pyrrolidin-2-one; for 3h; Commercially available Nalpha-(9-Fluorenylmethoxycarbonyl)-D-glutamic acid gamma-t-butyl ester (2.29 g), TBTU (1.73 g), HOBt (0.73 g) and DIPEA (1.9 mL) as a solution in NMP (25 mL) were added to compound 114 (3.3 g). The mixture was shaken for three hours. The reaction mixture was filtered through a glass sinter funnel then the solid was washed with N-methylpyrrolidine (3×25 mL), methanol (3×25 mL), and again with N-methylpyrrolidine (3×25 mL) to give compound 120.
  • 4
  • [ 59524-02-6 ]
  • [ 104091-08-9 ]
  • Boc-Ser(Fmoc-D-Glu(OtBu))-OBzl [ No CAS ]
  • 5
  • [ 140422-54-4 ]
  • [ 104091-08-9 ]
  • Boc-Thr(Fmoc-D-Glu(OtBu))-OBzl [ No CAS ]
  • 6
  • [ 84793-07-7 ]
  • [ 104091-08-9 ]
  • [ 1562-93-2 ]
  • N-[4-phenylazobenzoyl]-D-α-glutamyl-glutamic acid [ No CAS ]
  • 7
  • [ 104091-08-9 ]
  • Ac-Asp-D-Glu-Leu-Ile-Cha-Abu-OH [ No CAS ]
  • 8
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((E)-(S)-1-ethyl-2-hydroxy-pent-3-enylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 9
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((E)-(S)-1-ethyl-2-oxo-pent-3-enylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 10
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((S)-1-ethyl-2-oxo-pentylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 11
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((E)-(S)-1-ethyl-2-oxo-4-thiazol-2-yl-but-3-enylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 12
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((E)-(S)-1-ethyl-2-hydroxy-4-thiazol-2-yl-but-3-enylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 13
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((S)-1-ethyl-2-oxo-4-thiazol-2-yl-butylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 14
  • [ 104091-08-9 ]
  • [ 622841-43-4 ]
  • 15
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((S)-1-ethyl-2-oxo-4-phenyl-butylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 16
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((E)-(S)-1-ethyl-2-oxo-4-phenyl-but-3-enylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 17
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((E)-(S)-1-ethyl-2-hydroxy-4-phenyl-but-3-enylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 18
  • [ 104091-08-9 ]
  • [ 622841-15-0 ]
  • 19
  • [ 104091-08-9 ]
  • [ 622841-20-7 ]
  • 20
  • [ 104091-08-9 ]
  • [ 622841-25-2 ]
  • 21
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((E)-(S)-1-ethyl-2-hydroxy-8-methyl-non-3-enylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 22
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((E)-(S)-1-ethyl-8-methyl-2-oxo-non-3-enylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 23
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((S)-1-ethyl-8-methyl-2-oxo-nonylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butylcarbamoyl)-butyric acid [ No CAS ]
  • 24
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-[(S)-1-((1S,2S)-1-{(S)-2-cyclohexyl-1-[(E)-(S)-1-ethyl-4-(4-methoxy-phenyl)-2-oxo-but-3-enylcarbamoyl]-ethylcarbamoyl}-2-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-butyric acid [ No CAS ]
  • 25
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-[(S)-1-((1S,2S)-1-{(S)-2-cyclohexyl-1-[(E)-(S)-1-ethyl-2-hydroxy-4-(4-methoxy-phenyl)-but-3-enylcarbamoyl]-ethylcarbamoyl}-2-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-butyric acid [ No CAS ]
  • 26
  • [ 104091-08-9 ]
  • (R)-4-((S)-2-Acetylamino-3-carboxy-propionylamino)-4-[(S)-1-((1S,2S)-1-{(S)-2-cyclohexyl-1-[(S)-1-ethyl-4-(4-methoxy-phenyl)-2-oxo-butylcarbamoyl]-ethylcarbamoyl}-2-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-butyric acid [ No CAS ]
  • 27
  • [ 104091-08-9 ]
  • [ 622841-22-9 ]
  • 28
  • [ 104091-08-9 ]
  • [ 622841-24-1 ]
  • 29
  • [ 104091-08-9 ]
  • [ 622841-12-7 ]
  • 30
  • [ 104091-08-9 ]
  • [ 622841-17-2 ]
  • 31
  • [ 104091-08-9 ]
  • [ 622841-14-9 ]
  • 32
  • [ 104091-08-9 ]
  • [ 622841-19-4 ]
  • 33
  • [ 104091-08-9 ]
  • [ 622841-26-3 ]
  • 34
  • [ 104091-08-9 ]
  • [ 622841-21-8 ]
  • 35
  • [ 104091-08-9 ]
  • [ 622841-16-1 ]
  • 36
  • [ 104091-08-9 ]
  • [ 622841-23-0 ]
 

Historical Records

Technical Information

Categories